The "wait and see" era is over. This week’s earnings calls (Jan 27–28) confirmed a fundamental shift: The market is no longer rewarding medtech companies just for growing. It is rewarding them for resilience. Check back throughout the coming weeks as I cover additional companies and the running comparison chart grows. Reach out to us directly if you have a company you'd like included: hello@allons-y.co If you’re a CEO or CFO in this space, your 2026 playbook just changed. H